cefaclor anhydrous has been researched along with Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weinstein, AJ | 1 |
| Fillastre, JP; Godin, M; Humbert, G; Leroy, A | 1 |
| Gartenberg, G; Hirschmann, SZ; Meyers, BR; Srulevitch, E | 1 |
| Sekine, O; Usuda, Y | 1 |
1 review(s) available for cefaclor anhydrous and Kidney Diseases
| Article | Year |
|---|---|
The cephalosporins: activity and clinical use.
Topics: Cefaclor; Cefamandole; Cefatrizine; Cefazolin; Cefoxitin; Cefuroxime; Cephacetrile; Cephalexin; Cephaloglycin; Cephaloridine; Cephalosporins; Cephalothin; Cephapirin; Drug Hypersensitivity; Humans; Kidney Diseases | 1980 |
3 other study(ies) available for cefaclor anhydrous and Kidney Diseases
| Article | Year |
|---|---|
Cefaclor pharmacokinetics and renal impairment.
Topics: Cefaclor; Cephalexin; Half-Life; Humans; Kidney Diseases; Kinetics; Renal Dialysis | 1980 |
Pharmacokinetics of cefaclor in patients with stable renal impairment, and patients undergoing haemodialysis.
Topics: Adult; Aged; Cefaclor; Cephalexin; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Renal Dialysis; Time Factors | 1979 |
[Cefaclor dosage change with renal dysfunction].
Topics: Administration, Oral; Adult; Cefaclor; Cephalexin; Drug Evaluation; Female; Humans; Kidney Diseases; Male; Middle Aged | 1985 |